Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer

Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate of any other cancer of the female reproductive system. Epithelial ovarian cancer (EOC) accounts for approximately 90% of all ovarian malignancies. The standard therapeutic strategy includes cytoreductive...

Descripción completa

Detalles Bibliográficos
Autores principales: Revythis, Antonios, Limbu, Anu, Mikropoulos, Christos, Ghose, Aruni, Sanchez, Elisabet, Sheriff, Matin, Boussios, Stergios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317199/
https://www.ncbi.nlm.nih.gov/pubmed/35886427
http://dx.doi.org/10.3390/ijerph19148577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317199/
https://www.ncbi.nlm.nih.gov/pubmed/35886427
http://dx.doi.org/10.3390/ijerph19148577

Ejemplares similares